Frequently Asked Questions
What do I get with a $19 per-report purchase?
Full premium analysis for one company: valuation breakdown, revenue data, IPO timeline, readiness score, pre-IPO investor guide, bull/bear case with citations. One-time purchase — yours forever, no subscription needed.
What's included in the $49/mo Full Access plan?
Everything. All 450+ company reports, unlimited AI search, full S-1 filing analysis, and new reports the moment they're published. Always updated with the latest data. Cancel anytime.
What is Cap Table Pro and who is it for?
Cap Table Pro ($99/mo) is for investors who want detailed ownership data: cap tables, fully diluted share counts, option pool sizes, and IPO dilution scenarios for 450+ private companies. If you hold equity in pre-IPO companies and want to understand your ownership position at IPO, this is the right plan.
Can I cancel my subscription anytime?
Yes. Cancel at any time through Stripe — no contracts, no questions. You keep access until the end of your billing period.
What if I buy a single report and then subscribe later?
Full Access ($49/mo) unlocks everything, including all reports you'd otherwise buy individually. If you're interested in 3+ companies, Full Access is the better deal.
Is there a free tier?
Yes. 375+ company profiles, the IPO pipeline tracker, and 3 AI searches per day are always free. No account needed. Premium reports go deeper — full valuations, S-1 analysis, investor guides.
What payment methods are accepted?
All major credit and debit cards via Stripe. We never store card details.
What is the IPO Readiness Stack and who is it for?
The IPO Readiness Stack ($79 one-time) is for founders, CFOs, and executives evaluating whether and when to take their company public. It produces a 0–100 IPO readiness score across 5 dimensions, 3–4 comparable IPO case studies, a 3-scenario timeline, and 4–6 risk factors with mitigations. One-time purchase, permanent access.
What is the Investment Memo and who is it for?
The Investment Memo ($149 one-time) is for investors who need an institutional-grade capital decision document: a full bull/bear/base case investment thesis, comprehensive valuation analysis, a risk factor matrix, investor landscape, and a 12-month price target with upside scenarios. For investors making or advising on private company equity investments.